Omicron: Pfizer, BioNTech and Moderna race to tweak Covid vaccines against new Coronavirus variant November 27, 2021 Work is underway to look at tweaking vaccines against the new concerning strain of coronavirus that has sparked travel bans. The variant, named Omicron and designated a “variant of concern” by the World Health Organisation (WHO), has reached Belgium after being discovered in South Africa. The WHO warned that preliminary evidence suggests the variant has [...]
Historic pharma precedent: Pfizer agrees to share its Covid-19 pill secrets with dozens of companies around the world November 16, 2021 Pfizer’s new Covid-19 pill could be made available to more than half of the world’s population after the pharmaceutical giant signed a deal with a UN-backed group to allow other manufacturers to make its experimental pill. In a statement, Pfizer said it will grant a licence for the antiviral pill to the Geneva-based Medicines Patent [...]
Hikma expects trading to hit top end of guidance amid global vaccine growth November 4, 2021 Hikma Pharmaceuticals today said it expects its full year performance to be closer to the top end of its guidance after its global vaccine products delivered strong growth. Delivering a trading update this morning, the London-based manufacturer projected full year generic pharmaceuticals revenue to be in the range of $810m to $830m. It also expects [...]
Pfizer enjoys 130 per cent revenue boost as Covid-19 vaccine roll out continues November 2, 2021 Pharmaceutical giant and vaccine maker Pfizer has enjoyed a more than 130 per cent revenue boost in its third quarter, as the global vaccine drive continues. Pfizer pulled in a revenue of $24.1bn in its third quarter, up from $10.27bn in the same period last year. While revenue for its vaccine branch Comirnaty came in [...]
Socialising securely this winter October 29, 2021 | Sponsored Life has begun to return to what feels like normal after so many months of the pandemic stopping us doing the things we love. But as we look forward to Christmas, it’s important we remember that the virus is still with us – and we still need to take sensible precautions to make sure we [...]
How’s vaccine inequality driving up global inflation? October 27, 2021 | City Talk As the more highly vaccinated countries roll out Covid booster shots, other parts of the world are still struggling to get their first jab. The vaccine divide is more apparent in the emerging markets (EM). World organisations have voiced their concerns over “vaccine nationalism” whereby vaccine-exporting countries prioritise supply first for their own populations before [...]
Winter is coming – but we have the vaccines to keep us going October 26, 2021 | Sponsored It’s been impossible not to notice the temperatures falling and the winter nights slowly drawing in. Whilst we can look forward to cosy Autumnal nights and frosty winter walks, that change in the weather also means it’s time to redouble our efforts to fight not just Covid-19, but flu, too. Due to last year’s winter [...]
Covid-19 booster vaccinations: All your questions answered October 26, 2021 A third Covid shot is coming your way this winter as two jabs may not give us sufficient protection, or at least not in the long term. Booster jabs are being offered as part of a ramped-up vaccine campaign in England and City A.M. caught up with Phil Day, superintendent pharmacist at Pharmacy2U, to discuss [...]
GSK waves goodbye to West London as breakup begins with new £120m HQ October 11, 2021 GlaxoSmithKline will move its global headquarters to a new £120m site, as the pharmaceutical giant prepares to split up its empire into two separate businesses. The company today announced plans for a shiny new £120m headquarters in Weybridge for its new independent consumer healthcare company. Remaining pharmaceuticals and vaccine staff will also relocate from the [...]
Covid protection from Pfizer vaccine drops to 47 per cent six months after second dose October 5, 2021 The effectiveness of the Pfizer/BioNTech SE vaccine in preventing infection by the coronavirus dropped to 47 per cent from 88 per cent six months after the second dose, according to data published that U.S. health agencies considered when deciding on the need for booster shots. Watch the full report.